Cannabis Sativa, Inc. (CBDS)
USD 0.04
(7.34%)
USD 0.04
(7.34%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -855.85 Thousand USD | 34.92% |
| 2022 | -1.31 Million USD | 24.66% |
| 2021 | -1.74 Million USD | 31.41% |
| 2020 | -2.54 Million USD | -4.8% |
| 2019 | -2.42 Million USD | 51.82% |
| 2018 | -5.04 Million USD | 35.77% |
| 2017 | -7.84 Million USD | -177.32% |
| 2016 | -2.82 Million USD | 61.23% |
| 2015 | -7.29 Million USD | 49.3% |
| 2014 | -14.39 Million USD | -5726.27% |
| 2013 | -247.03 Thousand USD | -533.17% |
| 2012 | -39.01 Thousand USD | -249.41% |
| 2011 | -11.16 Thousand USD | 70.45% |
| 2010 | -37.79 Thousand USD | -6.01% |
| 2009 | -35.64 Thousand USD | -894.67% |
| 2008 | 4486.00 USD | -77.57% |
| 2007 | 20 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -174.79 Thousand USD | 19.51% |
| 2024 Q2 | -197.94 Thousand USD | -13.25% |
| 2023 Q3 | -221.52 Thousand USD | 27.33% |
| 2023 Q4 | -217.15 Thousand USD | 1.97% |
| 2023 Q1 | -112.36 Thousand USD | 73.75% |
| 2023 Q2 | -304.81 Thousand USD | -171.28% |
| 2023 FY | -855.85 Thousand USD | 34.92% |
| 2022 Q3 | -382.69 Thousand USD | -119.27% |
| 2022 Q2 | -174.52 Thousand USD | 47.09% |
| 2022 FY | -1.31 Million USD | 24.66% |
| 2022 Q4 | -428.01 Thousand USD | -11.84% |
| 2022 Q1 | -329.83 Thousand USD | 19.62% |
| 2021 Q3 | -372.42 Thousand USD | 23.99% |
| 2021 Q4 | -410.32 Thousand USD | -10.18% |
| 2021 Q1 | -634.71 Thousand USD | 15.28% |
| 2021 FY | -1.74 Million USD | 31.41% |
| 2021 Q2 | -489.93 Thousand USD | 22.81% |
| 2020 Q2 | -458.34 Thousand USD | 31.87% |
| 2020 FY | -2.54 Million USD | -4.8% |
| 2020 Q4 | -749.15 Thousand USD | -12.67% |
| 2020 Q3 | -664.9 Thousand USD | -45.07% |
| 2020 Q1 | -672.77 Thousand USD | 67.58% |
| 2019 Q1 | -737.81 Thousand USD | 61.68% |
| 2019 Q2 | -538.8 Thousand USD | 26.97% |
| 2019 Q3 | -453.04 Thousand USD | 15.92% |
| 2019 FY | -2.42 Million USD | 51.82% |
| 2019 Q4 | -2.07 Million USD | -358.11% |
| 2018 FY | -5.04 Million USD | 35.77% |
| 2018 Q2 | -1.09 Million USD | 16.43% |
| 2018 Q3 | -724.94 Thousand USD | 33.67% |
| 2018 Q4 | -1.92 Million USD | -165.6% |
| 2018 Q1 | -1.3 Million USD | 53.08% |
| 2017 Q3 | -1.14 Million USD | 40.22% |
| 2017 Q2 | -1.91 Million USD | 4.83% |
| 2017 FY | -7.84 Million USD | -177.32% |
| 2017 Q1 | -2 Million USD | -2.67% |
| 2017 Q4 | -2.78 Million USD | -144.09% |
| 2016 Q3 | -451.38 Thousand USD | -688.4% |
| 2016 Q2 | -57.25 Thousand USD | 81.96% |
| 2016 Q4 | -1.95 Million USD | -333.17% |
| 2016 FY | -2.82 Million USD | 61.23% |
| 2016 Q1 | -317.41 Thousand USD | 83.1% |
| 2015 Q2 | -1.86 Million USD | -5.04% |
| 2015 FY | -7.29 Million USD | 49.3% |
| 2015 Q4 | -1.87 Million USD | -6.13% |
| 2015 Q3 | -1.76 Million USD | 5.37% |
| 2015 Q1 | -1.78 Million USD | 87.34% |
| 2014 FY | -14.39 Million USD | -5726.27% |
| 2014 Q3 | -170.4 Thousand USD | -69.43% |
| 2014 Q2 | -100.57 Thousand USD | -55.83% |
| 2014 Q4 | -14.05 Million USD | -8149.3% |
| 2014 Q1 | -64.54 Thousand USD | -4.59% |
| 2013 Q1 | -3934.00 USD | 79.34% |
| 2013 FY | -247.03 Thousand USD | -533.17% |
| 2013 Q3 | -88.24 Thousand USD | -3378.12% |
| 2013 Q4 | -61.71 Thousand USD | 30.06% |
| 2013 Q2 | -2537.00 USD | 35.51% |
| 2012 Q4 | -19.04 Thousand USD | 22.34% |
| 2012 Q1 | 2196.00 USD | 117.1% |
| 2012 Q2 | 2348.00 USD | 6.92% |
| 2012 Q3 | -24.51 Thousand USD | -1144.21% |
| 2012 FY | -39.01 Thousand USD | -249.41% |
| 2011 FY | -11.16 Thousand USD | 70.45% |
| 2011 Q4 | -12.84 Thousand USD | -159.55% |
| 2011 Q2 | 1253.00 USD | -76.66% |
| 2011 Q3 | -4947.00 USD | -494.81% |
| 2011 Q1 | 5368.00 USD | 135.47% |
| 2010 Q2 | -11.7 Thousand USD | -338.6% |
| 2010 Q1 | 4904.00 USD | 131.93% |
| 2010 Q3 | -15.85 Thousand USD | -35.54% |
| 2010 FY | -37.79 Thousand USD | -6.01% |
| 2010 Q4 | -15.13 Thousand USD | 4.57% |
| 2009 FY | -35.64 Thousand USD | -894.67% |
| 2009 Q4 | -15.36 Thousand USD | -17.74% |
| 2009 Q1 | 4154.00 USD | 141.54% |
| 2009 Q2 | -11.39 Thousand USD | -374.29% |
| 2009 Q3 | -13.04 Thousand USD | -14.51% |
| 2008 FY | 4486.00 USD | -77.57% |
| 2008 Q4 | -10 Thousand USD | 0.0% |
| 2008 Q1 | 20 Thousand USD | 0.0% |
| 2008 Q3 | -10 Thousand USD | -200.0% |
| 2008 Q2 | 10 Thousand USD | -50.0% |
| 2007 FY | 20 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Achiko AG | -8.35 Million USD | 89.757% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | 4.7 Million USD | 118.199% |
| CompuMed, Inc. | -31.2 Thousand USD | -2642.94% |
| CompuGroup Medical SE & Co. KGaA | 171.25 Million USD | 100.5% |
| Cogstate Limited | 660.18 Thousand USD | 229.638% |
| CareView Communications, Inc. | -688.3 Thousand USD | -24.343% |
| Craneware plc | 19.73 Million USD | 104.337% |
| Caduceus Software Systems Corp. | -1.15 Million USD | 25.853% |
| Certive Solutions Inc. | -2.1 Million USD | 59.263% |
| Drug Free Solution, Inc. | -1.4 Million USD | 39.184% |
| DATATRAK International, Inc. | 1.87 Million USD | 145.55% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -1204.454% |
| Healixa Inc. | -6.35 Million USD | 86.529% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 9.02 Million USD | 109.486% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -983.56 Thousand USD | 12.984% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | -789.33 USD | -108327.654% |
| IQ-AI Limited | -517.25 Thousand USD | -65.459% |
| Cannabiz Mobile, Inc. | -750.00 USD | -114013.6% |
| Mednow Inc. | -17.04 Million USD | 94.978% |
| Galileo Life Sciences, Inc. | -271.37 Thousand USD | -215.38% |
| MediXall Group, Inc. | -6.54 Million USD | 86.914% |
| Mitesco, Inc. | -2.58 Million USD | 66.913% |
| MobileSmith, Inc. | -7.81 Million USD | 89.052% |
| NantHealth, Inc. | -51.32 Million USD | 98.333% |
| Net Medical Xpress Solutions, Inc. | -1.82 Million USD | 53.001% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.15 Million USD | 92.961% |
| Patient Access Solutions, Inc. | -9 Million USD | 90.495% |
| Pharma-Bio Serv, Inc. | 1.11 Million USD | 176.592% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 1245.29% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | -2409.83% |
| Renalytix Plc | -29.6 Million USD | 97.109% |
| Revium Recovery Inc. | -679 Thousand USD | -26.046% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | 396.65 Thousand USD | 315.77% |
| Vaso Corporation | 4.19 Million USD | 120.402% |
| Vynleads, Inc. | -235.73 Thousand USD | -263.065% |